back to
back to

Program: Sunday (04.11.2007)

08:30 – 10:00

Room: Großer Saal

Scientific Session Characterization of HRS Cells and "Stem Cells" in HL

  • Richard Ambinder
  • Ralf Küppers

  • Molecular Immunogenetics of B Cells and HRS Cells

    • Ralf Küppers

  • Translocations in HRS Cells

    • Reiner Siebert

  • The Plasticity of HRS Cells

    • Stephan Mathas

  • The Role of microRNA for Regulation of PRDM1/Blimp-1in HRS Cells

    • Wayne Tam

  • BIC and other miRNAs in HL

    • Anke van den Berg

  • HL: Evidence for a Cancer Stem Cell and Therapeutic Implications

    • Richard Ambinder

  • Induction of Hodgkin-like Phenotype by Epigenetic Reprogramming of B Cells

    • Michael Hummel

  • 3D Nuclear Organization of Telomeres in HRS Cells

    • Hans Knecht

10:30 – 12:00

Room: Großer Saal

Scientific Session Scientific Session on Translational Approaches

  • Michel Henry-Amar
  • Anas Younes

  • Antiangiogenic Agents

    • Peter Borchmann

  • KLHDC8B: a Candidate HL Susceptibility Gene

    • Matthew Mealiffe

  • Analysis of Genetic Predisposition to Hematotoxicity in HL

    • Daniel Re

  • Serum Profiling of Cytokines

    • Olivier Casasnovas

  • Targeted Treatment Approaches in HL

    • Martin Janz

  • How to Select Novel Small Molecules for Early Clinical Testing

    • Anas Younes

  • Proteomics Analysis of HL: Identification of New Players Involved in the Cross Talk between HRS Cells and Infiltrating Lymphocytes

    • Yue Ma

  • Galectin 1 Mediates Tumor Escape in HL

    • Margaret Shipp

12:15 – 13:45

Room: Großer Saal

Satellite Symposium (by Amgen GmbH) Prophylaxis and Treatment of Side Effects of Chemotherapy: Casuistic Forum

  • Anton Hagenbeek
  • Lorenz Trümper

  • Anaemia in Patients with Hodgkin Lymphoma

    • Anders Österborg

  • Neutropenia in Patients with Aggressive NHL

    • Frank Hartmann

  • Mucositis in Patients with Relapsed Lymphoma

    • Guido Kobbe

  • Concluding Remarks

    • Anton Hagenbeek
    • Lorenz Trümper

14:00 – 15:30

Room: Großer Saal

Satellite Symposium (by Ortho-Biotech) Innovative Strategies in the Therapy of Hematological Malignancies

  • Andreas Engert
  • Michael Hallek

  • Velcade – Lead Compound in Multiple Myeloma?

    • Martin Kropff

  • Future Directions in the Treatment of MDS

    • Ulrich Germing

  • Velcade – Innovative Therapy Options in NHL

    • Martin Gramatzki

  • Efficient Hb Management in Lymphoma: Results of the HD15 Protocol

    • Andreas Engert

16:00 – 17:30

Room: Großer Saal

Satellite Symposium (by Roche Pharma AG) Treatment of Lymphomas: Current Strategies and Future Outlook

  • Andreas Engert
  • Clemens Wendtner

  • Pathogenesis of B-Cell Lymphomas and Identification of Molecules Suitable for Targeted Therapy

    • Ioannis Anagnostopoulos

  • Review of Immuno-Chemotherapy in Aggressive and Follicular Lymphoma

    • Mathias Rummel

  • State of the Art Therapy Non Hodgkin Lymphoma in the USA

    • Richard Fisher

  • Role of Immuno-Chemotherapy in HL

    • Anas Younes

  • New treatment approaches in Aggressive Lymphoma: Intensified Immuno-Chemotherapy - Anti-VEGF + Immuno-Chemotherapy

    • Michael Pfreundschuh

  • New Treatment Approaches in HL: Emergence of Anti-VEGF as a New Modality in HL

    • Andreas Engert

17:30 – 20:00

Room: Großer Saal

Main Program Opening Ceremony

  • From the Absorbent Gland to the “Molecular Cure” of Hodgkin Lymphoma

    • Volker Diehl

20:00

Room: Weinkeller

Main Program Kick-off party

Archive

You a viewing the program of a past symposium. Click here to get back to the current conference.